Laurion Capital Management LP - BRIDGEBIO PHARMA INC ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$14,494,226
+23.1%
19,100,0000.0%0.09%
+33.3%
Q2 2023$11,771,71219,100,0000.07%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
INHERENT GROUP, LP 39,500,000$19,370,0003.63%
Athyrium Capital Management, LP 20,000,000$9,682,0003.44%
Diameter Capital Partners LP 65,894,000$31,800,0001.48%
Affinity Asset Advisors, LLC 10,000,000$4,680,0000.75%
Context Capital Management, LLC 22,958$11,209,0000.73%
DeepCurrents Investment Group LLC 39,355,000$18,879,0000.59%
ABSOLUTE INVESTMENT ADVISERS, LLC 5,000,000$2,373,0000.53%
Aequim Alternative Investments LP 35,000,000$16,380,0000.43%
Antara Capital LP 25,750,000$12,246,0000.37%
ARISTEIA CAPITAL, L.L.C. 31,816,000$15,472,0000.28%
View complete list of BRIDGEBIO PHARMA INC shareholders